Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains-Reference-Cited by-同舟云学术

Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains

Published:2008-06 Issue:11 Volume:73 Page:1282-1288
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Leung N.,Gertz M.A.,Zeldenrust S.R.,Rajkumar S.V.,Dispenzieri A.,Fervenza F.C.,Kumar S.,Lacy M.Q.,Lust J.A.,Greipp P.R.,Witzig T.E.,Hayman S.R.,Russell S.J.,Kyle R.A.,Winters J.L.

Publisher

Elsevier BV

Subject

Nephrology

Reference27 articles.

1. Renal failure in multiple myeloma. Pathogenesis and prognostic implications;Alexanian;Arch Intern Med,1990

2. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution;Blade;Arch Intern Med,1998

3. Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988;Rayner;Quart J Med,1991

4. Renal involvement in multiple myeloma: a 10-year study;Sakhuja;Renal Failure,2000

5. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group;Knudsen;Eur J Haematol,2000

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Renal Outcomes in Multiple Myeloma with Involved Free Light Chains Exceeding 1000 mg/L at Diagnosis: Insights from an Indian Cohort;Indian Journal of Hematology and Blood Transfusion;2024-09-05

2. Serum Free Light Chain Kinetics Is Predictive of Renal Response in Myeloma Patients With Renal Impairment—An ALLG Trial of Carfilzomib-Dexamethasone Therapy in Frontline and Relapse;Clinical Lymphoma Myeloma and Leukemia;2024-08

3. Recent Updates in the Diagnosis and Management of Kidney Diseases in Multiple Myeloma;Indian Journal of Nephrology;2024-07-24

4. Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy;Hematological Oncology;2024-06-14

5. Chemotherapy plus therapeutic plasmapheresis with 4% human albumin solution in multiple myeloma patients with acute kidney injury: a prospective, open-label, proof-of-concept study;Renal Failure;2024-05-27